142 related articles for article (PubMed ID: 32816408)
1. Eosinophilic dermatosis of hematologic malignancy effectively controlled with omalizumab maintenance therapy.
Lor M; Gates G; Yu Y
Dermatol Ther; 2020 Nov; 33(6):e14206. PubMed ID: 32816408
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of the management of eosinophilic dermatosis of hematological malignancy.
Tan S; Choong DJ; Tan E
Int J Dermatol; 2024 May; ():. PubMed ID: 38727148
[TBL] [Abstract][Full Text] [Related]
3. A Case of Eosinophilic Dermatosis of Hematologic Malignancy Treated With Narrow-Band Ultraviolet B (NBUVB).
Pan S; Bicknell L
Cureus; 2023 Mar; 15(3):e35734. PubMed ID: 37016657
[TBL] [Abstract][Full Text] [Related]
4. What's in a name? a new nomenclature has been proposed For eosinophilic dermatosis of hematologic malignancy (EDHM): hematologic-related malignancy-induced eosinophilic dermatosis (He Remained).
Cohen PR
Dermatol Online J; 2020 Jun; 26(6):. PubMed ID: 32815699
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy.
Maglie R; Ugolini F; De Logu F; Nassini R; Simi S; Nardiello P; Pasqualini E; Baroni G; Del Bianco E; Massi D; Antiga E
J Am Acad Dermatol; 2022 Oct; 87(4):761-770. PubMed ID: 34265409
[TBL] [Abstract][Full Text] [Related]
6. Eosinophilic Dermatosis of Hematologic Malignancy: Emerging Evidence for the Role of Insect Bites-A Retrospective Clinico-Pathological Study of 35 Cases.
Michelerio A; Rubatto M; Roccuzzo G; Coscia M; Quaglino P; Tomasini C
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792476
[No Abstract] [Full Text] [Related]
7. Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed.
Sibaud V; Brun A; Meyer N; Oberic L; Lamant L; Ysebaert L
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e213-e215. PubMed ID: 34657337
[No Abstract] [Full Text] [Related]
8. Eosinophilic dermatosis of hematologic malignancy: a case report.
Almeida FT; Caldas R; Rodrigues AP; Ferreira O; Brito C
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609451
[TBL] [Abstract][Full Text] [Related]
9. Long-term maintenance of eosinophilic dermatosis of hematologic malignancy with doxycycline.
Mieczkowska K; Rzepecki AK; Jacob J; Amin B; Jacobson M; McLellan BN
JAAD Case Rep; 2021 Oct; 16():110-112. PubMed ID: 34557577
[No Abstract] [Full Text] [Related]
10. Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease?
Qiao J; Sun CE; Zhu W; Zhu D; Fang H
Int J Clin Exp Pathol; 2013; 6(8):1683-7. PubMed ID: 23923089
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia.
Jin A; Pousti BT; Savage KT; Mollanazar NK; Lee JB; Hsu S
JAAD Case Rep; 2019 Sep; 5(9):815-817. PubMed ID: 31508473
[No Abstract] [Full Text] [Related]
12. Eosinophilic dermatosis of hematologic malignancy.
Martires K; Callahan S; Terushkin V; Brinster N; Leger M; Soter NA
Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329554
[TBL] [Abstract][Full Text] [Related]
13. Response to: "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia".
Maglie R; Grandi V; Antiga E
J Am Acad Dermatol; 2020 Jan; 82(1):e15-e16. PubMed ID: 31473299
[No Abstract] [Full Text] [Related]
14. Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin's B lymphoma: a single center prospective clinico-pathological study.
Michelerio A; Tomasini C; Fiandrino G; De Amici M; Varettoni M; Defrancesco I; Cavalloni C; Brazzelli V; Derlino F; Paulli M; Arcaini L; Vassallo C
Front Med (Lausanne); 2023; 10():1231003. PubMed ID: 37614953
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous sarcoidosis in a patient with severe asthma treated with omalizumab.
Yung S; Han D; Lee JK
Can Respir J; 2015; 22(6):315-6. PubMed ID: 26401982
[TBL] [Abstract][Full Text] [Related]
16. Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia.
Cohen PR
J Am Acad Dermatol; 2020 Jan; 82(1):e13-e14. PubMed ID: 31473296
[No Abstract] [Full Text] [Related]
17. Eosinophilic dermatosis of hematologic malignancy mimicking varicella zoster infection: report in a woman with chronic lymphocytic leukemia and review of the literature.
Bari O; Cohen PR
Dermatol Pract Concept; 2017 Jul; 7(3):6-15. PubMed ID: 29085714
[TBL] [Abstract][Full Text] [Related]
18. A case of eosinophilic dermatosis of hematologic malignancy with tissue-based Th2 cytokine profiling.
Xu S; Singh K; McNiff J; Damsky W; Gehlhausen JR
JAAD Case Rep; 2022 Dec; 30():5-7. PubMed ID: 36345409
[No Abstract] [Full Text] [Related]
19. Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study.
Detoraki A; Di Capua L; Varricchi G; Genovese A; Marone G; Spadaro G
J Asthma; 2016; 53(2):201-6. PubMed ID: 26377630
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Seasonality in Eosinophilic Dermatosis of Haematological Malignancy.
Brun A; Ysebaert L; Oberic L; Lamant L; Sibaud V
Acta Derm Venereol; 2024 Feb; 104():adv15768. PubMed ID: 38372473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
